6-K/A XBRL

FORM 6-K/A

Company: NeuroSense Therapeutics Ltd.
Filed: January 19, 2023
Period of Report: June 30, 2022
Accession Number: 0001213900-23-003794

View Document ↗ View on SEC.gov ↗